Mellou, K.; Tryfinopoulou, K.; Pappa, S.; Gkolfinopoulou, K.; Papanikou, S.; Papadopoulou, G.; Vassou, E.; Kostaki, E.-G.; Papadima, K.; Mouratidou, E.; Tsintziloni, M.; Siafakas, N.; Florou, Z.; Katsoulidou, A.; Sapounas, S.; Sourvinos, G.; Pournaras, S.; Petinaki, E.; Goula, M.; Paparizos, V.; Papa, A.; Zaoutis, T.; Paraskevis, D. Overview of Mpox Outbreak in Greece in 2022–2023; Is it over? Viruses2023, 15, 1384.
Mellou, K.; Tryfinopoulou, K.; Pappa, S.; Gkolfinopoulou, K.; Papanikou, S.; Papadopoulou, G.; Vassou, E.; Kostaki, E.-G.; Papadima, K.; Mouratidou, E.; Tsintziloni, M.; Siafakas, N.; Florou, Z.; Katsoulidou, A.; Sapounas, S.; Sourvinos, G.; Pournaras, S.; Petinaki, E.; Goula, M.; Paparizos, V.; Papa, A.; Zaoutis, T.; Paraskevis, D. Overview of Mpox Outbreak in Greece in 2022–2023; Is it over? Viruses 2023, 15, 1384.
Mellou, K.; Tryfinopoulou, K.; Pappa, S.; Gkolfinopoulou, K.; Papanikou, S.; Papadopoulou, G.; Vassou, E.; Kostaki, E.-G.; Papadima, K.; Mouratidou, E.; Tsintziloni, M.; Siafakas, N.; Florou, Z.; Katsoulidou, A.; Sapounas, S.; Sourvinos, G.; Pournaras, S.; Petinaki, E.; Goula, M.; Paparizos, V.; Papa, A.; Zaoutis, T.; Paraskevis, D. Overview of Mpox Outbreak in Greece in 2022–2023; Is it over? Viruses2023, 15, 1384.
Mellou, K.; Tryfinopoulou, K.; Pappa, S.; Gkolfinopoulou, K.; Papanikou, S.; Papadopoulou, G.; Vassou, E.; Kostaki, E.-G.; Papadima, K.; Mouratidou, E.; Tsintziloni, M.; Siafakas, N.; Florou, Z.; Katsoulidou, A.; Sapounas, S.; Sourvinos, G.; Pournaras, S.; Petinaki, E.; Goula, M.; Paparizos, V.; Papa, A.; Zaoutis, T.; Paraskevis, D. Overview of Mpox Outbreak in Greece in 2022–2023; Is it over? Viruses 2023, 15, 1384.
Abstract
In Μay 2022, for the first time, multiple cases of mpox were reported in several non-endemic countries. The first ever case of the disease in Greece was confirmed on 8 June 2022 and a total of 88 cases were reported in the country until the end of April 2023. A multidisciplinary response team was established by the Greek National Public Health Organization (EODY) to monitor and manage the situation. EODY’s emergency response focused on enhanced surveillance, laboratory testing, contact tracing, medical countermeasures, and education of health care providers and the public. Even though management of cases was considered successful and the risk from the disease was down-graded, sporadic cases continue to occur. Here, we provide epidemiological and laboratory features of the reported cases to depict the course of the disease notification rate, that suggests measures for raising awareness as well as vaccination of high-risk groups of the population should be continued.
Medicine and Pharmacology, Epidemiology and Infectious Diseases
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.